Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2019 08:00 ET | Source: Altimmune, Inc.

Altimmune Announces Successful Pre-IND Meeting with FDA

GAITHERSBURG, Md., June 10, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it successfully completed a pre-IND...
June 05, 2019 08:00 ET | Source: Altimmune, Inc.

Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs

GAITHERSBURG, Md., June 05, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biotechnology company, today announced that it has received additional patent protection for its...
May 14, 2019 16:15 ET | Source: Altimmune, Inc.

Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update

GAITHERSBURG, Md., May 14, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the first quarter ended March...
May 08, 2019 08:00 ET | Source: Altimmune, Inc.

Altimmune to Announce First Quarter 2019 Financial Results on May 15

GAITHERSBURG, Md., May 08, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the first...
April 11, 2019 09:27 ET | Source: Altimmune, Inc.

Altimmune To Present NasoVAX Phase 2 Data at the World Vaccine Congress in Washington, D.C.

GAITHERSBURG, Md., April 11, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced an oral presentation at the World Vaccine Congress...
April 01, 2019 16:20 ET | Source: Altimmune, Inc.

Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update

GAITHERSBURG, Md., April 01, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the year ended December 31,...
March 21, 2019 16:15 ET | Source: Altimmune, Inc.

Altimmune to Announce Year End 2018 Financial Results on April 2

GAITHERSBURG, Md., March 21, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the year...
March 19, 2019 07:00 ET | Source: Altimmune, Inc.

Altimmune Announces Positive Results from NasoVAX Extension Study

Seroprotective HAI antibody response persisted more than one year after vaccination Company seeking partnership for further development and commercialization of NasoVAX GAITHERSBURG, Md., March 19,...
March 14, 2019 09:00 ET | Source: Altimmune, Inc.

Altimmune to Participate at 31st Annual ROTH Conference

GAITHERSBURG, Md., March 14, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, announced today that Vipin K. Garg, Ph.D., President and Chief...
March 12, 2019 13:34 ET | Source: Altimmune, Inc.

Altimmune Announces Closing of $14 Million Registered Direct Offering

GAITHERSBURG, Md., March 12, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced the closing of the previously announced registered...